- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/26 - 2-Pyrrolidones
Patent holdings for IPC class C07D 207/26
Total number of patents in this class: 304
10-year publication summary
|
22
|
16
|
20
|
16
|
15
|
20
|
18
|
20
|
8
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| University of Southern California | 2119 |
15 |
| Novartis AG | 10420 |
10 |
| Cayman Chemical Company, Incorporated | 64 |
10 |
| Pfizer Inc. | 3389 |
8 |
| BASF SE | 21147 |
7 |
| Servier Pharmaceuticals, LLC | 111 |
6 |
| Glaxosmithkline Intellectual Property Development Limited | 772 |
5 |
| California Institute of Technology | 4015 |
5 |
| Theravance Biopharma R&D IP, LLC | 428 |
5 |
| Pardes Biosciences, Inc. | 20 |
5 |
| Takeda Pharmaceutical Company Limited | 2726 |
4 |
| Purdue Research Foundation | 3824 |
4 |
| OPKO Health, Inc. | 45 |
4 |
| PTC Therapeutics, Inc. | 485 |
4 |
| Richter Gedeon Nyrt. | 1709 |
4 |
| The Scripps Research Institute | 1346 |
4 |
| Yale University | 2482 |
4 |
| Corteva Agriscience LLC | 2643 |
4 |
| Bristol-myers Squibb Company | 4821 |
3 |
| F. Hoffmann-La Roche AG | 7847 |
3 |
| Other owners | 190 |